"Even with this larger trial size, we anticipate that initial results will be shared later this year, with a supplemental new ...

Available on the Suvoda Platform, the assistant aims to aid drug supply managers in accessing trial information via ... tables and charts, and can interact with users in their language of preference.

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

Opthea (ASX:OPT) has announced that its lead drug candidate sozinibercept has failed to meet primary endpoints in a phase 3 ...

Millions of Americans are born predisposed to high levels of a cholesterol called lipoprotein(a). Doctors are finally figuring out how to treat it.

Novo Nordisk's hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after ...

One trial, called EXTEND, was a four-month federally funded study that combined drugs with an exercise program. By his own admission, Santoro was previously never into fitness. But after three times a ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

Novo Nordisk shares fell after the pharmaceutical giant released fresh trial results for its CagriSema developmental weight-loss drug. The Danish company said CagriSema helped obese or overweight ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...